Ectica Technologies sponsors and exhibits at the Swiss Society for Biomaterials and Regen. Med 2022
Updated: Jan 26
Swiss Society for Biomaterials and Regenerative Medicine
Ectica Technologies is excited to sponsor the annual meeting of the Swiss Society for Biomaterials and Regenerative Medicine (SSB+RM) taking place from June 7th-9th at the ETH Zurich (Zurich, Switzerland). The meeting welcomes professionals in Switzerland and from abroad in the field of biomaterials and regenerative medicine.
26th Annual Meeting of the Swiss Society for Biomaterials and Regenerative Medicine (SSB+RM2022)
The 3 day conference is open to everybody interested in the scientific, technological and medical aspect of biomaterials. The meeting is aimed at scientists, engineers, medical doctors and industrial representatives who work with implant materials or tissue engineering for regenerative medicine. The topic this year: Biomaterials: from innovation to translation. A dedicated seminar organized for the Young Scientists of the SSB+RM will be held as a pre-meeting event on June 7 (included in the registration fee).
Tomographic imaging of organotypic cultures developed in the 3DProSeed hydrogel plate
Ectica Technologies and SCREEN will present their joint work related to label-free 3D tomographic imaging of organotypic cultures developed in the 3DProSeed hydrogel plate. The use of advanced ex vivo human organotypic cultures is rapidly growing in the field of oncology research and diagnostics, with a focus on patient-derived organoids and tumor tissue specimens cultured in artificial systems capable of replicating tumor development mechanisms. These mechanisms include metastasis, angiogenesis and formation of dysplasia. Our objective is to enhance the label-free imaging and analytical capabilities of these complex tissue samples to enable screening and diagnostics applications.
About Ectica Technologies and 3DProSeed hydrogel plate
The 3DProSeed hydrogel plate developed by Ectica Technologies offers the highest workflow integration in screening processes. No hydrogel assembly step is necessary: the hydrogels are pre-casted in the plate and delivered hydrated and ready for cell seeding. Thanks to the patented hydrogel surface, no cell encapsulation procedures are required. Additionally, the hydrogels, made of poly(ethylene glycol)-based bioconjugates, are fully synthetic and animal free and offer the highest control over the culture conditions, as well as the possibility to upgrade to GMP for cell therapy applications. Finally, various cell populations can be sequentially seeded at different time points to generate complex co-cultures. In this way, stromal environments can be created under controlled conditions, to which cancer cells can be subsequently added.